GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biomerica Inc (NAS:BMRA) » Definitions » E10

Biomerica (Biomerica) E10 : $-0.31 (As of Feb. 2024)


View and export this data going back to 1978. Start your Free Trial

What is Biomerica E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biomerica's adjusted earnings per share data for the three months ended in Feb. 2024 was $-0.110. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.31 for the trailing ten years ended in Feb. 2024.

During the past 3 years, the average E10 Growth Rate was -42.60% per year. During the past 5 years, the average E10 Growth Rate was -42.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biomerica was 32.60% per year. The lowest was -47.70% per year. And the median was -6.50% per year.

As of today (2024-04-29), Biomerica's current stock price is $0.66523. Biomerica's E10 for the quarter that ended in Feb. 2024 was $-0.31. Biomerica's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Biomerica was 280.00. The lowest was 10.14. And the median was 14.47.


Biomerica E10 Historical Data

The historical data trend for Biomerica's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomerica E10 Chart

Biomerica Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 -0.10 -0.16 -0.23 -0.29

Biomerica Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.28 -0.29 -0.30 -0.30 -0.31

Competitive Comparison of Biomerica's E10

For the Medical Devices subindustry, Biomerica's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomerica's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biomerica's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biomerica's Shiller PE Ratio falls into.



Biomerica E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biomerica's adjusted earnings per share data for the three months ended in Feb. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=-0.11/129.4194*129.4194
=-0.110

Current CPI (Feb. 2024) = 129.4194.

Biomerica Quarterly Data

per share eps CPI Adj_EPS
201405 0.020 100.373 0.026
201408 -0.030 100.352 -0.039
201411 -0.030 99.635 -0.039
201502 -0.020 99.032 -0.026
201505 0.040 100.333 0.052
201508 -0.010 100.548 -0.013
201511 -0.010 100.135 -0.013
201602 -0.020 100.040 -0.026
201605 -0.160 101.355 -0.204
201608 -0.010 101.617 -0.013
201611 -0.020 101.829 -0.025
201702 -0.040 102.779 -0.050
201705 -0.040 103.256 -0.050
201708 -0.020 103.587 -0.025
201711 -0.030 104.072 -0.037
201802 -0.040 105.052 -0.049
201805 -0.080 106.148 -0.098
201808 -0.050 106.383 -0.061
201811 -0.050 106.338 -0.061
201902 -0.070 106.649 -0.085
201905 -0.080 108.048 -0.096
201908 -0.050 108.245 -0.060
201911 -0.050 108.519 -0.060
202002 -0.090 109.139 -0.107
202005 -0.070 108.175 -0.084
202008 -0.160 109.662 -0.189
202011 -0.150 109.793 -0.177
202102 -0.180 110.968 -0.210
202105 -0.130 113.576 -0.148
202108 -0.120 115.421 -0.135
202111 -0.090 117.269 -0.099
202202 -0.010 119.703 -0.011
202205 -0.140 123.323 -0.147
202208 -0.160 124.958 -0.166
202211 -0.120 125.607 -0.124
202302 -0.120 126.928 -0.122
202305 -0.100 128.314 -0.101
202308 -0.070 129.538 -0.070
202311 -0.090 129.548 -0.090
202402 -0.110 129.419 -0.110

Add all the adjusted EPS together and divide 10 will get our e10.


Biomerica  (NAS:BMRA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Biomerica was 280.00. The lowest was 10.14. And the median was 14.47.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biomerica E10 Related Terms

Thank you for viewing the detailed overview of Biomerica's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomerica (Biomerica) Business Description

Traded in Other Exchanges
N/A
Address
17571 Von Karman Avenue, Irvine, CA, USA, 92614
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
Executives
John P. Kenny director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Zacharys Irani director, officer: Cheif Executive Officer 17571 VON KARMAN AVE., IRVINE CA 92614
Gary Lu officer: Chief Financial Officer 12136 AHERN CT, TUSTIN CA 92782
Allen Barbieri director
Catherine Coste director 966 OCHO RIOS DR, DANVILLE CA 94526
David Moatazedi director C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Steven Sloan officer: Chief Financial Officer 114 TERRAPIN, IRVINE CA 92618
Mark A Sirgo director C/O BIODELIVERY SCIENCES INTERNATIONAL, 801 CORPORATE CENTER DRIVE -SUITE 210, RALEIGH NC 27607
Francis Cano director 11 ACORN LANE, LOS ALTOS CA 94022
Francis E Capitanio officer: President-diagnostics 1533 MONROVIA AVENUE, NEWPORT BEACH CA 92663
Janet Moore director, 10 percent owner, officer: Secretary 1533 MUNROVIA AVE, NEWPORT BEACH CA 92663
Jane Emerson director 1533 MONROVIA AVE, NEWPORT BEACH CA 92663
William Snider other: Greater than 5% holder 4800 MONTGOMERY LANE, SUITE 230, BETHESDA MD 20814
Broadoak Fund The other: Greater than 5% holder 7201 WISCONSIN AVE. #630, BETHESDA MD 20814
John Roehm director 1533 MONROVIA AVE., NEWPORT BEACH CA 92663